[1] |
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109-119.
|
[2] |
World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
|
[3] |
Wu Q, Chen B, Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot[J]. Stem Cells Int, 2016, 2016: 4612167.
|
[4] |
黄晨, 王倩, 罗文峰, 等. 腔内血管成形术联合干细胞外泌体改善大鼠糖尿病足微循环的研究[J]. 实用放射学杂志, 2021, 37(12): 2082-2085.
|
[5] |
Zhang Y, Wang ZL, Deng ZP, et al. An extracellular matrix-inspired self-healing composite hydrogel for enhanced platelet-rich plasma-mediated chronic diabetic wound treatment[J]. Carbohydr Polym, 2023, 315: 120973.
|
[6] |
Schär MO, Diaz-Romero J, Kohl S, et al. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro[J]. Clin Orthop Relat Res, 2015, 473(5): 1635-1643.
|
[7] |
Armstrong EJ, Brodmann M, Deaton DH, et al. Dissections after infrainguinal percutaneous transluminal angioplasty: a systematic review and current state of clinical evidence[J]. J Endovasc Ther, 2019, 26(4): 479-489.
|
[8] |
Vossen RJ, Vahl AC, Leijdekkers VJ, et al. Long-term clinical outcomes of percutaneous transluminal angioplasty with optional stenting in patients with superficial femoral artery disease: a retrospective, observational analysis[J]. Eur J Vasc Endovasc Surg, 2018, 56(5): 690-698.
|
[9] |
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
|
[10] |
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006[M]. Geneva: WHO Document Production Services, 2006.
|
[11] |
World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation, 2011[EB/OL]. [2013-11-12].
URL
|
[12] |
中华医学会糖尿病分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
[13] |
中国医疗保健国际交流促进会糖尿病足病分会. 中国糖尿病足诊治指南[J]. 中华医学杂志, 2017, 97(4): 251-258.
|
[14] |
李茂全. 糖尿病足介入综合诊治临床指南(第六版)[J]. 介入放射学杂志, 2020, 29(9): 853-866.
|
[15] |
Norgren L, HiattWR, Dormandy JA, et al. TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II)[J]. J Vasc Surg, 2007, 45(1)(suppl 1): S5-S67.
|
[16] |
Malas MB, Qazi U, Glebova N, et al. Design of the revascularization with open bypass vs angioplasty and stenting of the lower extremity trial (ROBUST): a randomized clinical trial[J]. JAMA Surg, 2014, 149(12): 1289-1295.
|
[17] |
Allaqaband S, Kirvaitis R, Jan F, et al. Endovascular treatment of peripheral vascular disease[J]. Curr Probl Cardiol, 2009, 34(9): 359-476.
|
[18] |
Heublein H, Bader A, Giri S. Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds[J]. Drug Discov Today, 2015, 20(6): 703-175.
|
[19] |
Gong F, Zhang Y, Gao J, et al. Effect of platelet-rich plasma vs standard management for the treatment of diabetic foot ulcer wounds: a meta-analysis[J]. Int Wound J, 2023, 20(1): 155-163.
|
[20] |
Deng J, Yang M, Zhang X, et al. Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials[J]. J Orthop Surg Res, 2023, 18(1): 370.
|
[21] |
Elsaid A, El-Said M, Emile S, et al. Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers[J].World J Surg, 2020, 44(4): 1294-1301.
|
[22] |
Chen L, Wu D, Zhou L, et al. Platelet-rich plasma promotes diabetic ulcer repair through inhibition of ferroptosis[J]. Ann Transl Med, 2022, 10(20): 1121.
|
[23] |
Chen C, Wang Q, Li D, et al. MALAT1 participates in the role of platelet-rich plasma exosomes in promoting wound healing of diabetic foot ulcer[J]. Int J Biol Macromol, 2023, 238: 124170.
|
[24] |
Zhou J, Liu Y, Liu X, et al. Hyaluronic acid-based dual network hydrogel with sustained release of platelet-rich plasma as a diabetic wound dressing[J]. Carbohydr Polym, 2023, 314: 120924.
|
[25] |
Chen T, Song P, He M, et al. Sphingosine-1-phosphate derived from PRP-exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signaling pathway[J]. Burns Trauma,2023, 11: tkad003.
|
[26] |
刘贯英, 邓晓龙, 王敏哲, 等. 自体富血小板凝胶在糖尿病足中的作用机制与应用[J].医学研究杂志, 2015, 44(9): 4-6, 56.
|
[27] |
刘贯英, 邓晓龙, 孙玥, 等. 自体富血小板凝胶用于糖尿病足溃疡的治疗效果[J]. 西安交通大学学报, 2016, 37(2): 264-267.
|
[28] |
Wang Y, Wang Y, Wang X, et al. Effect of leukocyte-platelet fibrin-rich wound reconstruction followed by full-thickness skin grafting in the treatment of diabetic foot Wagner grade 4 ulcer gangrene (toe area)[J]. Platelets, 2023, 34(1): 2131752.
|
[29] |
Orban YA, Soliman MA, Hegab YH, et al. Autologous platelet-rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers[J]. Wounds, 2022, 33(2): 36-42.
|
[30] |
Zhao P, Zhou G, Jiang J, et al. Platelet-rich plasma (PRP) in the treatment of diabetic foot ulcers and its regulation of autophagy[J]. Int J Low Extrem Wounds, 2023, 18:15347346221144937.
|
[31] |
Bakadia BM, Qaed Ahmed AA, Lamboni L, et al. Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressings[J]. Bioact Mater, 2023, 28: 74-94.
|
[32] |
Huang Q, Wu T, Guo Y, et al. Platelet-rich plasma-loaded bioactive chitosan@sodium alginate@gelatin shell-core fibrous hydrogels with enhanced sustained release of growth factors for diabetic foot ulcer healing[J]. Int J Biol Macromol, 2023, 234: 123722.
|
[33] |
Qian Z, Wang H, Bai Y, et al. Improving chronic diabetic wound healing through an injectable and self-healing hydrogel with platelet-rich plasma release[J]. ACS Appl Mater Interfaces, 2020, 12(50): 55659-55674.
|
[34] |
Eldin M, Abd Elaziz A, Mohamed Hamada N, et al. Role of platelet rich plasma in accelerating the healing rate of diabetic foot ulcer[J]. QJM-Int J Med, 2023, 114: hcab092.
|